KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,690,651 | -42.5% | 282,043 | -26.2% | 0.01% | -44.4% |
Q2 2023 | $82,898,069 | +11.0% | 382,283 | -7.0% | 0.02% | +12.5% |
Q1 2023 | $74,671,478 | +66.1% | 411,096 | +79.7% | 0.02% | +33.3% |
Q4 2022 | $44,947,607 | +7.6% | 228,741 | +23.2% | 0.01% | +20.0% |
Q3 2022 | $41,773,000 | +9.8% | 185,712 | -38.2% | 0.01% | +11.1% |
Q2 2022 | $38,036,000 | +83.8% | 300,662 | +84.3% | 0.01% | +200.0% |
Q1 2022 | $20,689,000 | +106.6% | 163,170 | +113.4% | 0.00% | – |
Q4 2021 | $10,016,000 | -3.2% | 76,466 | -9.6% | 0.00% | -100.0% |
Q3 2021 | $10,350,000 | -16.2% | 84,610 | -21.9% | 0.00% | 0.0% |
Q2 2021 | $12,355,000 | -20.3% | 108,383 | -15.9% | 0.00% | -66.7% |
Q1 2021 | $15,501,000 | -16.7% | 128,930 | -29.6% | 0.00% | +50.0% |
Q4 2020 | $18,608,000 | +154.8% | 183,166 | +93.9% | 0.00% | +100.0% |
Q3 2020 | $7,304,000 | -35.2% | 94,460 | -6.5% | 0.00% | -66.7% |
Q2 2020 | $11,264,000 | +167.2% | 101,059 | +72.6% | 0.00% | +200.0% |
Q1 2020 | $4,216,000 | – | 58,557 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |